Editorial
Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response
Submitted: 14 March 2024 | Published: 30 November 2023
About the author(s)
Michael Mynhardt, Group Executive at Avacare Health Global, Managing Director at Barrs Pharmaceutical Industries (Pty) Ltd, South AfricaNicaise Ndembi, Office of The Director General of The Africa Center for Disease Control and Prevention (Africa CDC), Souh Africa
Full Text:
PDF (155KB)Abstract
No abstract available.
Keywords
Metrics
Total abstract views: 1733Total article views: 1176
Crossref Citations
1. The influence of institutional logics on vaccine development, production and distribution in Africa
Richard Chawana, Anastacia Mamabolo, Evangelos Apostoleris
International Journal of Operations & Production Management vol: 45 issue: 2 first page: 355 year: 2025
doi: 10.1108/IJOPM-11-2023-0896
2. Rethinking corruption: a decolonial inquiry into the intersection of historical systems and anti-corruption efforts
Nana Koomson, Tolulope Ojo, Eustace Orleans-Lindsay, Andrea Bowra
Journal of Pharmaceutical Health Services Research vol: 16 issue: 3 year: 2025
doi: 10.1093/jphsr/rmaf010
3. The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic
Andrew Hill, Mark J Siedner, Cassandra Fairhead, Francois Venter
Clinical Infectious Diseases vol: 81 issue: 3 first page: 547 year: 2025
doi: 10.1093/cid/ciaf115
